Twist Bioscience Corp
Twist Bioscience Corp
SOUTH SAN FRANCISCO, CA
Loading...
Price History
Market Data
| Market Cap | 3.65B |
| P/E Ratio | - |
| P/B Ratio | 8.00 |
| EPS | -1.28 |
| Dividend Yield | - |
| D/E Ratio | 0.40 |
| Current Ratio | 3.78 |
| Currency | USD |
Key Financial Metrics
391.56M
Revenue
-76.58M
Net Income
-1.28
EPS (Diluted)
-151.25M
Free Cash Flow
Profitability
Gross Margin
51.6%
Operating Margin
-34.4%
Net Profit Margin
-19.6%
EBITDA
-90.68M
Returns & Efficiency
Return on Assets (ROA)
-12.0%
Return on Equity (ROE)
-16.8%
Dividend Yield
-
EPS
-1.28
Financial Health
Total Assets
638.09M
Total Debt
-
Debt to Equity
0.40x
Current Ratio
3.78
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | SOUTH SAN FRANCISCO, CA |
| Fiscal Year | 2025 |
Peers
AMGEN INC
AMGN
178.75B
P/E: --
GILEAD SCIENCES INC
GILD
169.44B
P/E: --
169.44B
P/E: --
BIOGEN IDEC INC.
BIIB
28.13B
P/E: --
BIOGEN INC.
BIIB
28.13B
P/E: --
MODERNA, INC.
MRNA
19.39B
P/E: --
Moderna, Inc.
MRNA
19.39B
P/E: --
19.11B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$3.65B
P/E Ratio (TTM)-
Price to Book8.00
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin51.6%
Operating Margin-34.4%
Net Margin-19.6%
ROE-16.8%
ROA-12.0%
Leverage & Liquidity
Debt to Equity0.40
Current Ratio3.78
Total Debt-
Total Assets$638.09M
Stockholders' Equity$456.10M
Income Statement (FY 2025)
Revenue$391.56M
Gross Profit$202.13M
Operating Income$-134.51M
Net Income$-76.58M
EPS (Diluted)$-1.28
Cash Flow (FY 2025)
Free Cash Flow$-151.25M
Cash & Equivalents$148.59M
Revenue Growth4.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 681 GATEWAY BLVD. SOUTH SAN FRANCISCO, CA 94080 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 462058888 |
| Fiscal Year End | 0930 |
| Shares Outstanding | 61.08M |
| Stockholders' Equity | $456.10M |
| Cash & Equivalents | $148.59M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-04
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-29
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Twist Bioscience Corp |
| Ticker | TWST |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | SOUTH SAN FRANCISCO, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 3.65B |
| Revenue | 391.56M |
| Net Income | -76.58M |
| P/E Ratio | - |
| EPS | -1.28 |
| Net Margin | -19.6% |
| ROE | -16.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...